Vanguard Group
ALIM

Vanguard Group’s Alimera Sciences ALIM Stock Holding History

Vanguard Group’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,177,745
Closed -$6.55M – 4402
2024
Q2 		$6.55M Buy
1,177,745
+132,285
+13% +$470K ﹤0.01% 3130
2024
Q1 		$4.08M Buy
1,045,460
+396,506
+61% +$1.51M ﹤0.01% 3377
2023
Q4 		$2.8M Buy
648,954
+502,268
+342% +$1.7M ﹤0.01% 3478
2023
Q3 		$455K Buy
146,686
+5,293
+4% +$17.5K ﹤0.01% 4078
2023
Q2 		$413K Sell
141,393
-7,231
-5% -$16.6K ﹤0.01% 4172
2023
Q1 		$312K Hold
148,624
– – ﹤0.01% 4237
2022
Q4 		$403K Buy
148,624
+58
+0% +$247 ﹤0.01% 4158
2022
Q3 		$755K Sell
148,566
-793
-0.5% -$4.83K ﹤0.01% 4084
2022
Q2 		$817K Buy
149,359
+3,726
+3% +$20.5K ﹤0.01% 4151
2022
Q1 		$815K Sell
145,633
-1,230
-0.8% -$5.99K ﹤0.01% 4271
2021
Q4 		$753K Hold
146,863
– – ﹤0.01% 4342
2021
Q3 		$619K Hold
146,863
– – ﹤0.01% 4348
2021
Q2 		$1.34M Buy
146,863
+20,905
+17% +$205K ﹤0.01% 4088
2021
Q1 		$1.21M Buy
125,958
+7,519
+6% +$61.6K ﹤0.01% 3973
2020
Q4 		$499K Buy
118,439
+1
+0% +$4 ﹤0.01% 3950
2020
Q3 		$576K Sell
118,438
-1
-0% -$6 ﹤0.01% 3784
2020
Q2 		$746K Hold
118,439
– – ﹤0.01% 3683
2020
Q1 		$474K Hold
118,439
– – ﹤0.01% 3685
2019
Q4 		$897K Sell
118,439
-3
-0% -$18 ﹤0.01% 3667
2019
Q3 		$1.01M Buy
118,442
+4,409
+4% +$40.1K ﹤0.01% 3652
2019
Q2 		$1.52M Buy
114,033
+87
+0.1% +$1.23K ﹤0.01% 3551
2019
Q1 		$1.81M Buy
113,946
+1,847
+2% +$28.1K ﹤0.01% 3483
2018
Q4 		$1.21M Sell
112,099
-27,202
-20% -$396K ﹤0.01% 3508
2018
Q3 		$2.05M Buy
139,301
+496
+0.4% +$7.55K ﹤0.01% 3518
2018
Q2 		$2.04M Sell
138,805
-1,207
-0.9% -$17K ﹤0.01% 3495
2018
Q1 		$2.16M Buy
140,012
+2,031
+1% +$36K ﹤0.01% 3431
2017
Q4 		$2.75M Hold
137,981
– – ﹤0.01% 3327
2017
Q3 		$2.79M Buy
137,981
+31,230
+29% +$668K ﹤0.01% 3304
2017
Q2 		$2.23M Sell
106,751
-15,355
-13% -$329K ﹤0.01% 3347
2017
Q1 		$2.56M Buy
122,106
+19,234
+19% +$370K ﹤0.01% 3300
2016
Q4 		$1.67M Sell
102,872
-15,237
-13% -$279K ﹤0.01% 3415
2016
Q3 		$2.64M Buy
118,109
+41,029
+53% +$944K ﹤0.01% 3291
2016
Q2 		$1.42M Buy
77,080
+1,721
+2% +$45.8K ﹤0.01% 3494
2016
Q1 		$1.98M Buy
75,359
+6,007
+9% +$187K ﹤0.01% 3388
2015
Q4 		$2.52M Buy
69,352
+5,326
+8% +$231K ﹤0.01% 3300
2015
Q3 		$2.12M Buy
64,026
+5,462
+9% +$308K ﹤0.01% 3353
2015
Q2 		$4.05M Buy
58,564
+1,499
+3% +$103K ﹤0.01% 3114
2015
Q1 		$4.29M Buy
57,065
+2,433
+4% +$191K ﹤0.01% 3073
2014
Q4 		$4.54M Buy
54,632
+8,209
+18% +$666K ﹤0.01% 2945
2014
Q3 		$3.77M Buy
46,423
+7,761
+20% +$663K ﹤0.01% 2985
2014
Q2 		$3.47M Buy
38,662
+9,466
+32% +$841K ﹤0.01% 3017
2014
Q1 		$3.46M Buy
29,196
+12,203
+72% +$1.19M ﹤0.01% 2997
2013
Q4 		$1.2M Buy
16,993
+278
+2% +$11.3K ﹤0.01% 3364
2013
Q3 		$943K Buy
16,715
+165
+1% +$10.4K ﹤0.01% 3385
2013
Q2 		$1.21M Buy
+16,550
New +$955K ﹤0.01% 3250

Vanguard Group's ALIM Position: Q3 2024 in Review

Vanguard Group sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 1,177,745 shares — an estimated $6.55M sold.

Vanguard Group first reported a position in ALIM in Q2 2013 and held it in 45 quarters. The position peaked at $6.55M in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.

  • Vanguard Group reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
  • Vanguard Group sold 1,177,745 Alimera Sciences shares in Q3 2024, an estimated $6.55M.
  • Vanguard Group first reported a position in Alimera Sciences in Q2 2013 and held it in 45 quarters.
  • Vanguard Group's Alimera Sciences position peaked at $6.55M in Q2 2024.
  • 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.

Based on Vanguard Group's 13F filing for Q3 2024, filed 13 Nov 2024.